Metastatic Myoepithelial Carcinoma Ex Pleomorphic Adenoma of the Sublingual Salivary Gland
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Myoepithelial carcinoma ex pleomorphic adenoma is a very rare malignant neoplasm of the salivary gland. Owing to its rarity, its clinical features and treatment are not well characterized. We describe a case of a patient who was referred to our department with a six-month history of a bulge on the right side of the floor of the mouth and a submandibular mass with progressive enlargement. The mass was resected, and an elective level I neck dissection was performed. Histological examination revealed myoepithelial carcinoma ex pleomorphic adenoma of the sublingual salivary gland. Thoracic computed tomography and biopsy revealed lung metastases. The patient died two years after the diagnosis.
References
1.
Xu B, Katabi N
. Myoepithelial Carcinoma. Surg Pathol Clin. 2021; 14(1):67-73.
PMC: 8522910.
DOI: 10.1016/j.path.2020.09.008.
View
2.
Ghaloo S, Qayyum M, Shaikh O, Faisal M, Keerio A, Hussain R
. Carcinoma ex-pleomorphic adenoma of mandible: A case report and review of literature. Int J Surg Case Rep. 2022; 100:107729.
PMC: 9596728.
DOI: 10.1016/j.ijscr.2022.107729.
View
3.
Wakasaki T, Kubota M, Nakashima Y, Tomonobe E, Mihara T, Fukushima J
. Invasive myoepithelial carcinoma ex pleomorphic adenoma of the major salivary gland: two case reports. BMC Cancer. 2016; 16(1):827.
PMC: 5084397.
DOI: 10.1186/s12885-016-2871-3.
View
4.
Cormier C, Agarwal S
. Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression. Head Neck Pathol. 2021; 16(1):322-330.
PMC: 9018951.
DOI: 10.1007/s12105-021-01346-0.
View
5.
Panelli Santos K, Matsuzaki H, Unetsubo T, Tsuyoshi S, Nagatsuka H, Asaumi J
. myoepithelial carcinoma with multiple metastases arising from a submandibular salivary gland: A case report. Oncol Lett. 2017; 13(4):2679-2683.
PMC: 5403181.
DOI: 10.3892/ol.2017.5783.
View